Anorexia in cancer: role of feeding-regulatory peptides
- PMID: 16815804
- PMCID: PMC1642704
- DOI: 10.1098/rstb.2006.1863
Anorexia in cancer: role of feeding-regulatory peptides
Abstract
Anorexia is one of the most common symptoms in advanced cancer and is a frequent cause of discomfort for cancer patients and their families. The pathogenesis of cancer anorexia is multi-factorial and involves most of the hypothalamic neuronal signalling pathways modulating energy homeostasis. It is considered to be the result of a failure of usual appetite and satiety signals. Loss of appetite can arise from decreased taste and smell of food, as well as from dysfunctional hypothalamic signalling pathways and cytokine production. Cytokines in particular, appear to play a key role in energy balance through persistent activation of the melanocortin system and inhibition of the neuropeptide Y pathway. The imbalance between anorexigenic and orexigenic peptides leads to suppression of appetite, and increased satiety and satiation associated with marked weight loss and decline in physical performance. High levels of serotonin also appear to contribute to these effects and recent findings implicate corticotropin-releasing factor in the pathogenesis of cancer anorexia as well. Despite significant advances in our understanding of the regulation of food intake and energy expenditure, few effective therapies are available. A better appreciation of the molecular and neuronal mechanisms that control body weight homeostasis may lead to the development of new therapies for improving the survival and quality of life of these patients.
Figures

Similar articles
-
Improving food intake in anorectic cancer patients.Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):421-6. doi: 10.1097/01.mco.0000078985.18774.4b. Curr Opin Clin Nutr Metab Care. 2003. PMID: 12806216 Review.
-
Cancer anorexia-cachexia syndrome: are neuropeptides the key?Cancer Res. 1999 Sep 15;59(18):4493-501. Cancer Res. 1999. PMID: 10493494 Review.
-
[Recent development in research and management of cancer anorexia-cachexia syndrome].Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9. Gan To Kagaku Ryoho. 2005. PMID: 15984510 Review. Japanese.
-
Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat.Clin Sci (Lond). 2001 Feb;100(2):221-9. Clin Sci (Lond). 2001. PMID: 11171292
-
Anorexia of aging.Vitam Horm. 2013;92:319-55. doi: 10.1016/B978-0-12-410473-0.00013-1. Vitam Horm. 2013. PMID: 23601431 Review.
Cited by
-
Distribution of selenium and oxidative stress in breast tumor-bearing mice.Nutrients. 2013 Feb 20;5(2):594-607. doi: 10.3390/nu5020594. Nutrients. 2013. PMID: 23429470 Free PMC article.
-
The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis.Cannabis Cannabinoid Res. 2021 Dec;6(6):474-487. doi: 10.1089/can.2021.0048. Epub 2021 Oct 18. Cannabis Cannabinoid Res. 2021. PMID: 34664988 Free PMC article.
-
Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.Transl Psychiatry. 2011 Jul 26;1(7):e23. doi: 10.1038/tp.2011.25. Transl Psychiatry. 2011. PMID: 22832525 Free PMC article.
-
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.Oncologist. 2010;15(2):200-11. doi: 10.1634/theoncologist.2009-0153. Epub 2010 Feb 15. Oncologist. 2010. PMID: 20156909 Free PMC article. Clinical Trial.
-
Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.Front Vet Sci. 2025 Feb 18;11:1490290. doi: 10.3389/fvets.2024.1490290. eCollection 2024. Front Vet Sci. 2025. PMID: 40046187 Free PMC article. Review.
References
-
- Agnello D, Wang H, Yang H, Tracey K.J, Ghezzi P. HMGB-1, a DNA-binding protein with cytokines activity, induces brain TNF and IL-6 production, and mediates anorexia and test aversion. Cytokines. 2002;18:231–236. doi:10.1006/cyto.2002.0890 - DOI - PubMed
-
- Aleman M.R, Santolaria F, Batista N, de La Vega M, Gonzales-Reimers E, Milena A, Llanos M, Gomez-Sirvent J.L. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 2002;19:21–26. doi:10.1006/cyto.2002.1051 - DOI - PubMed
-
- Argiles J.M, Moore-Carrasco R, Busquets S, Lopez-Soriano F.J. Catabolic mediators as targets for cancer cachexia. Drug Disc. Today. 2003;8:838–844. doi:10.1016/S1359-6446(03)02826-5 - DOI - PubMed
-
- Asakawa A, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337–345. doi:10.1053/gast.2001.22158 - DOI - PubMed
-
- Barber M.D, Ross J.A, Fearon K.C. Cancer cachexia. Surg. Oncol. 1999;8:133–141. doi:10.1016/S0960-7404(99)00045-6 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources